"Anthraquinones" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds based on ANTHRACENES which contain two KETONES in any position. Substitutions can be in any position except on the ketone groups.
| Descriptor ID |
D000880
|
| MeSH Number(s) |
D02.455.426.559.847.117.159 D02.806.100 D04.615.117.159
|
| Concept/Terms |
Anthraquinones- Anthraquinones
- Anthranoids
- Anthraquinone Derivatives
- Derivatives, Anthraquinone
- Anthracenediones
- Anthraquinone Compounds
- Compounds, Anthraquinone
|
Below are MeSH descriptors whose meaning is more general than "Anthraquinones".
Below are MeSH descriptors whose meaning is more specific than "Anthraquinones".
This graph shows the total number of publications written about "Anthraquinones" by people in this website by year, and whether "Anthraquinones" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anthraquinones" by people in Profiles.
-
Medicinal Mascarene Aloes: An audit of their phytotherapeutic potential. Fitoterapia. 2018 Jan; 124:120-126.
-
Pharmacological inhibition of pleckstrin homology domain leucine-rich repeat protein phosphatase is neuroprotective: differential effects on astrocytes. J Pharmacol Exp Ther. 2013 Nov; 347(2):516-28.
-
Molecular biology, phytochemistry and bioactivity of three endemic Aloe species from Mauritius and R?union Islands. Phytochem Anal. 2010 Nov-Dec; 21(6):566-74.
-
Caffeine, quercetin and alizarin stimulate the exhalation of metabolic products of [14C]-N-nitrosodiethylamine in mice. Indian J Exp Biol. 2002 Jun; 40(6):739-44.
-
The role of structural factors of anthraquinone compounds and their quinone-modified analogues in NADH dehydrogenase-catalysed oxygen radical formation. Anticancer Drug Des. 1998 Dec; 13(8):923-39.
-
Pharmacokinetics, cerebrospinal fluid penetration, and metabolism of piroxantrone in the rhesus monkey. Invest New Drugs. 1993 Nov; 11(4):255-61.
-
Phase I study of high-dose piroxantrone with granulocyte colony-stimulating factor. J Clin Oncol. 1993 Sep; 11(9):1795-803.
-
Pharmacokinetics of piroxantrone in a phase I trial of piroxantrone and granulocyte-colony stimulating factor. Cancer Res. 1993 Jun 01; 53(11):2587-90.
-
Mitoxantrone and VP-16 in refractory acute myelogenous leukemia. Onkologie. 1986 Jun; 9(3):148-50.
-
Novantrone for childhood malignant solid tumors. A pediatric oncology group phase II study. Invest New Drugs. 1986; 4(1):43-8.